Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Implant endosseous root-form

XiVE S plus Impl D3.8/L9.5: medical device reports filed with FDA

3,967 reports name it, 2019–2026. Manufacturer given most often on reports: Dentsply Implants Manufacturing. Product code DZE.

3,967
device reports naming the brand
0% of all MAUDE reports · about 560 a year
393
reports, 12 months to August 2026
614 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

3,967 medical device reports received by FDA name the brand "XiVE S plus Impl D3.8/L9.5" (implant endosseous root-form); the manufacturer given most often on reports is Dentsply Implants Manufacturing; received from June 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

393 reports arrived in the 12 months to August 2026, down 36% from 614 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (39%), osseointegration problem (32%) and loss of osseointegration (24.5%). The patient problems coded most often are failure of implant, inflammation and osteolysis. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

053105Sep 2021: 40Oct 2021: 45Nov 2021: 53Dec 2021: 502022Jan 2022: 58Feb 2022: 105Mar 2022: 49Apr 2022: 51May 2022: 72Jun 2022: 73Jul 2022: 55Aug 2022: 52Sep 2022: 39Oct 2022: 66Nov 2022: 69Dec 2022: 712023Jan 2023: 54Feb 2023: 54Mar 2023: 59Apr 2023: 66May 2023: 75Jun 2023: 74Jul 2023: 67Aug 2023: 44Sep 2023: 56Oct 2023: 40Nov 2023: 49Dec 2023: 422024Jan 2024: 51Feb 2024: 63Mar 2024: 45Apr 2024: 54May 2024: 50Jun 2024: 55Jul 2024: 50Aug 2024: 51Sep 2024: 42Oct 2024: 79Nov 2024: 50Dec 2024: 262025Jan 2025: 53Feb 2025: 37Mar 2025: 88Apr 2025: 28May 2025: 40Jun 2025: 53Jul 2025: 70Aug 2025: 48Sep 2025: 66Oct 2025: 32Nov 2025: 22Dec 2025: 202026Jan 2026: 62Feb 2026: 27Mar 2026: 27Apr 2026: 42May 2026: 21Jun 2026: 30Jul 2026: 25Aug 2026: 19

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

05111,0212019: 8020192021: 1,02120212022: 76020222023: 68020232024: 61620242025: 55720252026: 2532026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%3,966
Malfunction0%1
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%3,967
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate1,54939%62.8%
Osseointegration problem1,26932%7.7%
Loss of osseointegration97224.5%22.4%
Fracturea broken bone1774.5%1.6%
Loosening of implant not related to bone-ingrowth30.1%0.1%
Malposition of device30.1%0.1%
Device dislodged or dislocated10%0%
Material deformation10%0.1%
Mechanical problema mechanical problem10%0.1%
Migration or expulsion of device10%0%
Positioning failure10%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant3,96599.9%
Inflammationinflammation43611%
Osteolysis2355.9%
Pocket erosion1523.8%
Implant pain100.3%
Inadequate osseointegration60.2%
Deformity/ disfigurement40.1%
Painpain, site not specified40.1%
Erosion20.1%
Swelling/ edema20.1%
Fistula10%
Foreign body in patientpart of a device left in the patient10%
Impaired healingslow healing10%
Laceration(s)10%
Paresthesia10%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureXiVE S plus Impl D3.8/L9.5Product code DZEAll MAUDE reports
Reports3,9673,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about XiVE S plus Impl D3.8/L9.5 reports

How many FDA reports name XiVE S plus Impl D3.8/L9.5?

3,967 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 393 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (39%), osseointegration problem (32%), loss of osseointegration (24.5%), fracture (4.5%) and loosening of implant not related to bone-ingrowth (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that XiVE S plus Impl D3.8/L9.5 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.